Reported about 10 hours ago
Carlyle Group is set to sell up to a 10% stake in Piramal Pharma, aiming to raise between 26 billion to 27 billion rupees ($304.8 million to $320 million) through block trades, according to Moneycontrol. The firm currently holds an 18% stake in the Indian pharmaceutical company.
Source: YAHOO